You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CE

Nurse View: Updates on Therapies in HR-Positive Breast Cancer

  • Authors: Theresa Gillespie, PhD, MA, RN, FAAN
  • CE Released: 1/20/2021
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 1/20/2022
Start Activity


Target Audience and Goal Statement

This activity is intended for nurses and nurse practitioners.

The goal of this activity is to improve the knowledge and competence of nurses regarding pharmacologic features, adverse events (AEs), management strategies, and patient counseling tips regarding cyclin-dependent kinase (CDK) 4/6 and phosphoinositide 3-kinase (PI3K) inhibitors in hormone receptor (HR)-positive breast cancer (BC).

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Key pharmacologic features of CDK 4/6 and PI3K inhibitors in HR-positive BC, including mechanism of action, dosing, administration, or potential AEs
  • Have greater competence related to
    • Managing AEs associated with CDK 4/6 inhibitors and PI3K inhibitors in HR-positive BC


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • Theresa Gillespie, PhD, MA, RN, FAAN

    ​Professor of Surgery and Hematology and Oncology​
    Emory University School of Medicine​
    Winship Cancer Institute​
    Atlanta, Georgia​

    Disclosures

    Disclosure: Theresa Gillespie, PhD, MA, RN, FAAN, has disclosed no relevant financial relationships.

Editors

  • Vickie Phoenix, BS

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Vickie Phoenix, BS, has disclosed no relevant financial relationships.

  • Jason Luis Quinones, PhD

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Disclosure: Jason Luis Quinones, PhD, has disclosed no relevant financial relationships.

CE Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Nurses

  • Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CE

Nurse View: Updates on Therapies in HR-Positive Breast Cancer

Authors: Theresa Gillespie, PhD, MA, RN, FAANFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CE Released: 1/20/2021

Valid for credit through: 1/20/2022

processing....

A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

  • Print